Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 83 articles:
HTML format

Single Articles

    March 2023
  1. HUANG JQ, Duan LX, Liu QY, Li HF, et al
    Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3beta Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer.
    Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02645.
    PubMed     Abstract available

    February 2023
  2. LIU B, Zhang J, Meng X, Xie SM, et al
    HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer.
    Oncogene. 2023 Feb 23. doi: 10.1038/s41388-023-02641.
    PubMed     Abstract available

  3. SINGH A, Busacca S, Gaba A, Sheaff M, et al
    BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms.
    Oncogene. 2023;42:572-585.
    PubMed     Abstract available

    January 2023
  4. WANG L, Li D, Su X, Zhao Y, et al
    AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner.
    Oncogene. 2023;42:62-77.
    PubMed     Abstract available

    December 2022
  5. IWAI M, Kajino T, Nakatochi M, Yanagisawa K, et al
    Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer.
    Oncogene. 2022 Dec 15. doi: 10.1038/s41388-022-02546.
    PubMed     Abstract available

  6. SHIA DW, Choi W, Vijayaraj P, Vuong V, et al
    Targeting PEA3 transcription factors to mitigate small cell lung cancer progression.
    Oncogene. 2022 Dec 13. doi: 10.1038/s41388-022-02558.
    PubMed     Abstract available

  7. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    Correction: S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2022 Dec 7. doi: 10.1038/s41388-022-02564.

  8. AN J, Nagaki Y, Motoyama S, Kuze Y, et al
    Identification of Galectin-7 as a crucial metastatic enhancer of squamous cell carcinoma associated with immunosuppression.
    Oncogene. 2022;41:5319-5330.
    PubMed     Abstract available

    November 2022
  9. THIRUSANGU P, Ray U, Sarkar Bhattacharya S, Oien DB, et al
    Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Oncogene. 2022 Nov 28. doi: 10.1038/s41388-022-02470.

    October 2022
  10. SEMBA S, Trapasso F, Fabbri M, McCorkell KA, et al
    Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Oncogene. 2022 Oct 20. pii: 10.1038/s41388-022-02472.

    September 2022
  11. ZHENG QW, Ni QZ, Zhu B, Liang X, et al
    PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.
    Oncogene. 2022;41:4244-4256.
    PubMed     Abstract available

  12. HU M, Bao R, Lin M, Han XR, et al
    ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.
    Oncogene. 2022;41:4547-4559.
    PubMed     Abstract available

    August 2022
  13. HAMAD SH, Montgomery SA, Simon JM, Bowman BM, et al
    Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
    Oncogene. 2022 Aug 25. pii: 10.1038/s41388-022-02442.

  14. YI Y, Li P, Huang Y, Chen D, et al
    P21-activated kinase 2-mediated beta-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer.
    Oncogene. 2022 Aug 19. pii: 10.1038/s41388-022-02438.
    PubMed     Abstract available

    July 2022
  15. BIAN T, Wang Y, Botello JF, Hu Q, et al
    LKB1 phosphorylation and deactivation in lung cancer by NNAL, a metabolite of tobacco-specific carcinogen, in an isomer-dependent manner.
    Oncogene. 2022 Jul 14. pii: 10.1038/s41388-022-02410.
    PubMed     Abstract available

  16. THIRUSANGU P, Ray U, Sarkar Bhattacharya S, Oien DB, et al
    PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Oncogene. 2022 Jul 8. pii: 10.1038/s41388-022-02391.
    PubMed     Abstract available

  17. YOU A, Tian W, Yuan H, Gu L, et al
    TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.
    Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02402.
    PubMed     Abstract available

  18. ALFARO-ARNEDO E, Lopez IP, Pineiro-Hermida S, Canalejo M, et al
    IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression.
    Oncogene. 2022;41:3625-3639.
    PubMed     Abstract available

  19. ZENG Z, Xu S, Wang F, Peng X, et al
    HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps.
    Oncogene. 2022;41:3719-3731.
    PubMed     Abstract available

    June 2022
  20. GALLARDO A, Molina A, Asenjo HG, Lopez-Onieva L, et al
    EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.
    Oncogene. 2022 Jun 9. pii: 10.1038/s41388-022-02375.
    PubMed     Abstract available

  21. UESHIMA S, Fang J
    Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
    Oncogene. 2022;41:3370-3380.
    PubMed     Abstract available

    May 2022
  22. HAMAD SH, Montgomery SA, Simon JM, Bowman BM, et al
    TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
    Oncogene. 2022 May 16. pii: 10.1038/s41388-022-02348.
    PubMed     Abstract available

  23. LU X, Wang J, Wang W, Lu C, et al
    Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.
    Oncogene. 2022 May 4. pii: 10.1038/s41388-022-02292.
    PubMed     Abstract available

  24. LI X, Chen H, Zhang L, Chen L, et al
    27-hydroxycholesterol linked high cholesterol diet to lung adenocarcinoma metastasis.
    Oncogene. 2022;41:2685-2695.
    PubMed     Abstract available

    April 2022
  25. LIU Y, Luo Y, Yan S, Lian YF, et al
    CRL2(KLHDC3) mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression.
    Oncogene. 2022 Apr 25. pii: 10.1038/s41388-022-02318.
    PubMed     Abstract available

  26. TYAGI A, Wu SY, Sharma S, Wu K, et al
    Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
    Oncogene. 2022 Apr 23. pii: 10.1038/s41388-022-02322.
    PubMed     Abstract available

  27. BAUMER N, Tiemann J, Scheller A, Meyer T, et al
    Targeted siRNA nanocarrier: a platform technology for cancer treatment.
    Oncogene. 2022;41:2210-2224.
    PubMed     Abstract available

  28. IKEUCHI H, Hirose T, Ikegami M, Takamochi K, et al
    Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.
    Oncogene. 2022;41:2470-2479.
    PubMed     Abstract available

    March 2022
  29. WANG C, Zhang S, Ma B, Fu Y, et al
    TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02260.
    PubMed     Abstract available

  30. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    PubMed     Abstract available

  31. MA G, Deng Y, Qian L, Vallega KA, et al
    Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both.
    Oncogene. 2022;41:1691-1700.
    PubMed     Abstract available

  32. JEONG HS, Lee DH, Kim SH, Lee CH, et al
    Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1.
    Oncogene. 2022;41:1634-1646.
    PubMed     Abstract available

  33. HONG SY, Lu YC, Hsiao SH, Kao YR, et al
    Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
    Oncogene. 2022;41:1907-1917.
    PubMed     Abstract available

    February 2022
  34. TSUBOYAMA N, Wang R, Szczepanski AP, Chen H, et al
    Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02240.
    PubMed     Abstract available

  35. LIAO CG, Liang XH, Ke Y, Yao L, et al
    Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis.
    Oncogene. 2022 Feb 7. pii: 10.1038/s41388-022-02213.
    PubMed     Abstract available

  36. JIN Y, Pan Y, Zheng S, Liu Y, et al
    Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
    Oncogene. 2022 Feb 5. pii: 10.1038/s41388-022-02203.
    PubMed     Abstract available

  37. CHO HC, Huang Y, Hung JT, Hung TH, et al
    Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus.
    Oncogene. 2022;41:1155-1165.
    PubMed     Abstract available

    January 2022
  38. MEINHARDT AL, Munkhbaatar E, Hockendorf U, Dietzen M, et al
    The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
    Oncogene. 2022 Jan 29. pii: 10.1038/s41388-021-02161.
    PubMed     Abstract available

  39. JIN X, Zhang B, Zhang H, Yu H, et al
    Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.
    Oncogene. 2022;41:538-549.
    PubMed     Abstract available

  40. ALAM SK, Zhang Y, Wang L, Zhu Z, et al
    DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma.
    Oncogene. 2022;41:83-98.
    PubMed     Abstract available

    December 2021
  41. ALHAYYANI S, McLeod L, West AC, Balic JJ, et al
    Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer.
    Oncogene. 2021 Dec 3. pii: 10.1038/s41388-021-02134.
    PubMed     Abstract available

  42. BISCHOFF P, Trinks A, Obermayer B, Pett JP, et al
    Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
    Oncogene. 2021;40:6748-6758.
    PubMed     Abstract available

  43. LIU R, Gou D, Xiang J, Pan X, et al
    O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Oncogene. 2021;40:6707-6719.
    PubMed     Abstract available

  44. CHEN Z, Yu D, Owonikoko TK, Ramalingam SS, et al
    Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib.
    Oncogene. 2021;40:6653-6665.
    PubMed     Abstract available

    November 2021
  45. SHIN DH, Kim SH, Choi M, Bae YK, et al
    Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1.
    Oncogene. 2021 Nov 6. pii: 10.1038/s41388-021-02097.
    PubMed     Abstract available

  46. LI M, Li X, Goldsmith JR, Shi S, et al
    Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8.
    Oncogene. 2021;40:6456-6468.
    PubMed     Abstract available

  47. ROUKENS MG, Frederiks CL, Seinstra D, Braccioli L, et al
    Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation.
    Oncogene. 2021;40:6343-6353.
    PubMed     Abstract available

    October 2021
  48. INGRAM K, Samson SC, Zewdu R, Zitnay RG, et al
    NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
    Oncogene. 2021 Oct 23. pii: 10.1038/s41388-021-02076.
    PubMed     Abstract available

  49. CHEN J, Guanizo A, Luong Q, Jayasekara WSN, et al
    Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Oncogene. 2021 Oct 21. pii: 10.1038/s41388-021-02070.
    PubMed     Abstract available

  50. LIANG SK, Hsu CC, Song HL, Huang YC, et al
    Correction: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Oncogene. 2021 Oct 12. pii: 10.1038/s41388-021-02044.

    September 2021
  51. TAKAGI S, Sasaki Y, Koike S, Takemoto A, et al
    Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis.
    Oncogene. 2021;40:5548-5558.
    PubMed     Abstract available

  52. XU G, Yang Z, Ding Y, Liu Y, et al
    The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.
    Oncogene. 2021;40:5482-5494.
    PubMed     Abstract available

    August 2021
  53. LEONARD MK, Puts GS, Pamidimukkala N, Adhikary G, et al
    Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01998.
    PubMed     Abstract available

  54. MELOCCHI V, Dama E, Mazzarelli F, Cuttano R, et al
    Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Oncogene. 2021;40:4980-4991.
    PubMed     Abstract available

    July 2021
  55. CHEN CH, Wang BW, Hsiao YC, Wu CY, et al
    PKCdelta-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs.
    Oncogene. 2021;40:4796-4808.
    PubMed     Abstract available

  56. WU J, Li L, Zhang H, Zhao Y, et al
    A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
    Oncogene. 2021;40:4413-4424.
    PubMed     Abstract available

    June 2021
  57. LIANG SK, Hsu CC, Song HL, Huang YC, et al
    FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Oncogene. 2021 Jun 21. pii: 10.1038/s41388-021-01895.
    PubMed     Abstract available

  58. LIU W, Huang Y, Wang D, Han F, et al
    MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01857.
    PubMed     Abstract available

  59. YANG X, Chen Y, Zhou Y, Wu C, et al
    GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01837.
    PubMed     Abstract available

  60. LI M, Shi M, Hu C, Chen B, et al
    MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation.
    Oncogene. 2021;40:3870-3884.
    PubMed     Abstract available

    May 2021
  61. XU Q, Zhang J, Telfer BA, Zhang H, et al
    The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01798.
    PubMed     Abstract available

  62. VENUGOPALAN A, Lynberg M, Cultraro CM, Nguyen KDP, et al
    SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.
    Oncogene. 2021;40:3331-3346.
    PubMed     Abstract available

  63. RANGEL DF, Dubeau L, Park R, Chan P, et al
    Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
    Oncogene. 2021;40:3624-3632.
    PubMed     Abstract available

  64. ZHANG Q, Tang Q, Liu W, Hu C, et al
    Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm.
    Oncogene. 2021;40:3492-3509.
    PubMed     Abstract available

  65. WU S, Liu B, Zhang Y, Hong R, et al
    Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter.
    Oncogene. 2021;40:3449-3459.
    PubMed     Abstract available

    April 2021
  66. XU L, Liu W, Li T, Hu Y, et al
    Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-beta/Smad signaling pathway in lung cancer.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01760.
    PubMed     Abstract available

  67. ALI MM, Di Marco M, Mahale S, Jachimowicz D, et al
    LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression.
    Oncogene. 2021;40:2463-2478.
    PubMed     Abstract available

  68. PAN Y, Han H, Labbe KE, Zhang H, et al
    Recent advances in preclinical models for lung squamous cell carcinoma.
    Oncogene. 2021;40:2817-2829.
    PubMed     Abstract available

  69. MA S, Zhang L, Ren Y, Dai W, et al
    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
    Oncogene. 2021;40:2596-2609.
    PubMed     Abstract available

    March 2021
  70. MENG C, Zhan J, Chen D, Shao G, et al
    The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.
    Oncogene. 2021;40:1706-1720.
    PubMed     Abstract available

  71. TURGU B, Zhang F, El-Naggar A, Negri GL, et al
    HACE1 blocks HIF1alpha accumulation under hypoxia in a RAC1 dependent manner.
    Oncogene. 2021;40:1988-2001.
    PubMed     Abstract available

  72. CHEN L, Zhang Y, Shu X, Chen Q, et al
    Proteasome regulation by reversible tyrosine phosphorylation at the membrane.
    Oncogene. 2021;40:1942-1956.
    PubMed     Abstract available

  73. GUO Z, Dai Y, Hu W, Zhang Y, et al
    The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3.
    Oncogene. 2021;40:1821-1835.
    PubMed     Abstract available

    February 2021
  74. WU R, Li K, Yuan M, Luo KQ, et al
    Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01691.
    PubMed     Abstract available

  75. LIU PI, Chang AC, Lai JL, Lin TH, et al
    Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases.
    Oncogene. 2021;40:1503-1515.
    PubMed     Abstract available

  76. CHENG FJ, Chen CH, Tsai WC, Wang BW, et al
    Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
    Oncogene. 2021;40:1162-1175.
    PubMed     Abstract available

    January 2021
  77. ALSAFADI S, Dayot S, Tarin M, Houy A, et al
    Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Oncogene. 2021;40:85-96.
    PubMed     Abstract available

  78. HE D, Wang D, Lu P, Yang N, et al
    Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    Oncogene. 2021;40:355-368.
    PubMed     Abstract available

  79. TANG L, Xiong W, Zhang L, Wang D, et al
    circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.
    Oncogene. 2021;40:307-321.
    PubMed     Abstract available

  80. LIU X, Wang F, Xu C, Chen X, et al
    Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
    Oncogene. 2021;40:821-832.
    PubMed     Abstract available

  81. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    PubMed     Abstract available

  82. GUHA P, Gardell J, Rabinowitz B, Lopes M, et al
    Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific.
    Oncogene. 2021;40:693-704.
    PubMed     Abstract available

    October 2020
  83. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.